mProX™ Human EPHA5 Stable Cell Line
- Product Category:
- Membrane Protein Stable Cell Lines
- Subcategory:
- Kinase Cell Lines
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number
Made to Order Inquiry
InquiryProduct Information
Product Properties
Protocols
Please visit our protocols page.
Customer Reviews
Jennifer
Verified Customer
Sarah
Verified Customer
Any questions about our products? Please visit our frequently asked questions page.
Published Data
Fig.1 Knockdown of EphA5 promoted the proliferation, migration, and invasion of ESCC cells in vitro.
In order to investigate the functions of EphA5, siRNA was transfected into KYSE150 and KYSE450 cells. The transfection markedly reduced the expression of EphA5 mRNA and protein.
Ref: Zhang, Rui, et al. "EphA5 knockdown enhances the invasion and migration ability of esophageal squamous cell carcinoma via epithelial-mesenchymal transition through activating Wnt/β-catenin pathway." Cancer cell international 20 (2020): 1-12.
Pubmed: 31956298
DOI: 10.1186/s12935-020-1101-x
Research Highlights
According to this study, EphA5 may be a target for epigenetic silencing in cases of primary prostate cancer. It may also be a useful prognostic indicator and therapeutic marker for the disease.
Li, Shibao, et al. "Downregulation of EphA5 by promoter methylation in human prostate cancer." BMC cancer 15 (2015): 1-10.
Pubmed:
25609195
DOI:
10.1186/s12885-015-1025-3
A novel monoclonal antibody targeting human EphA5 enhanced the radiosensitivity of lung cancer cells and human lung cancer xenografts, resulting in a notable extension of survival, indicating the possibility of translational uses.
Staquicini, Fernanda I., et al. "Receptor tyrosine kinase EphA5 is a functional molecular target in human lung cancer." Journal of Biological Chemistry 290.12 (2015): 7345-7359.
Pubmed:
25623065
DOI:
10.1074/jbc.M114.630525